In 2023, healthcare buyouts returned to pre-pandemic levels after a Covid-induced surge. However, signs point to an increased level of activity in 2024 as companies and investors seek to bridge the valuation gap and create new opportunities. From the impact of generative AI to India’s emergence as an investment hub, we explore what’s happened, why, and what’s next.
